Sample size and optimal designs in stratified comparative trials to establish the equivalence of treatment effects among two ethnic groups.
نویسندگان
چکیده
When a new investigational medicine is intended to be applied to populations with different ethnic backgrounds, a stratified comparative phase III trial using ethnic groups as strata may be conducted to assess the influence of ethnic factors on clinical outcomes of this new medicine. In this paper, based on a binomial model with odds ratio as the measure of the treatment effect, we derive the score test and the associated sample size formula for establishing the equivalence/noninferiority of the treatment effects of a medicine among two ethnic groups. A simplified test together with its sample size formula are also given. Taking into account the sample size, cost, and power of testing, respectively, we derive the optimal design parameters, i.e., the allocation among treatment groups and ethnic groups, based on the simplified test.
منابع مشابه
Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
Two-stage designs are commonly used for Phase II trials. Optimal two-stage designs have the lowest expected sample size for a specific treatment effect, for example, the null value, but can perform poorly if the true treatment effect differs. Here we introduce a design for continuous treatment responses that minimizes the maximum expected sample size across all possible treatment effects. The p...
متن کاملThe Comparative Study of Obesity Differences for Schoolchildren between Turkman and Sisstanish Ethnic Groups in the North of Iran
Abstract Background and purpose: Overweight and obesity are the health problem in adolescents and the main purpose of this study was to evaluate this problem and some socio-demographicrelated factors among two ethnic groups in Iranian northern primary school children in 2010. Materials and Methods: This was a descriptive and cross-sectional study that performed on 4165 students (Turkman = 2852a...
متن کاملOptimal multistage designs for randomised clinical trials with continuous outcomes
Multistage designs allow considerable reductions in the expected sample size of a trial. When stopping for futility or efficacy is allowed at each stage, the expected sample size under different possible true treatment effects (δ) is of interest. The δ-minimax design is the one for which the maximum expected sample size is minimised amongst all designs that meet the types I and II error constra...
متن کاملComparative Effects of Zinc Sulfate and Hydroxyzine in Decreasing Pruritus among Hemodialysis Patients: A Cross-over Clinical Trial
Background and purpose: Uremic pruritus is a common complication in patients with chronic kidney disease, for which different treatments are applied. This study aimed to compare the effects of Zinc sulfate with Hydroxyzine in reducing pruritus in hemodialysis patients. Materials and methods: In this cross over randomized trial, 100 hemodialysis patients with uremic pruritus who met the study i...
متن کاملAdaptive enrichment in biomarker-stratified clinical trial design
In Phase II oncology trials, targeted therapies are being constantly evaluated for their efficacy in specific populations of interest. Such trials require designs that allow for stratification based on the participants’ biomarker signature. One of the disadvantages of a targeted design (defined as enrichment in biomarker-positive sub-population) is that if the drug has at least some activity in...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of biopharmaceutical statistics
دوره 12 4 شماره
صفحات -
تاریخ انتشار 2002